Swiss National Bank’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-196,000
| Closed | -$653K | – | 2508 |
|
|
2023
Q4 | $653K | Sell |
196,000
-13,100
| -6% | -$43.6K | ﹤0.01% | 2426 |
|
|
2023
Q3 | $782K | Buy |
209,100
+29,800
| +17% | +$111K | ﹤0.01% | 2374 |
|
|
2023
Q2 | $766K | Buy |
179,300
+45,000
| +34% | +$192K | ﹤0.01% | 2432 |
|
|
2023
Q1 | $919K | Sell |
134,300
-15,900
| -11% | -$109K | ﹤0.01% | 2302 |
|
|
2022
Q4 | $1.19M | Buy |
150,200
+3,300
| +2% | +$26.1K | ﹤0.01% | 2251 |
|
|
2022
Q3 | $1.41M | Buy |
146,900
+1,700
| +1% | +$16.3K | ﹤0.01% | 2115 |
|
|
2022
Q2 | $1.05M | Hold |
145,200
| – | – | ﹤0.01% | 2331 |
|
|
2022
Q1 | $1.88M | Buy |
145,200
+11,300
| +8% | +$146K | ﹤0.01% | 2072 |
|
|
2021
Q4 | $2.14M | Hold |
133,900
| – | – | ﹤0.01% | 2016 |
|
|
2021
Q3 | $2.15M | Buy |
133,900
+5,500
| +4% | +$88.4K | ﹤0.01% | 2004 |
|
|
2021
Q2 | $1.78M | Sell |
128,400
-3,300
| -3% | -$45.6K | ﹤0.01% | 2189 |
|
|
2021
Q1 | $1.92M | Buy |
131,700
+3,100
| +2% | +$45.3K | ﹤0.01% | 2027 |
|
|
2020
Q4 | $2.24M | Hold |
128,600
| – | – | ﹤0.01% | 1833 |
|
|
2020
Q3 | $2.36M | Buy |
128,600
+3,400
| +3% | +$62.4K | ﹤0.01% | 1637 |
|
|
2020
Q2 | $2.24M | Buy |
125,200
+23,200
| +23% | +$414K | ﹤0.01% | 1651 |
|
|
2020
Q1 | $1.65M | Buy |
102,000
+1,900
| +2% | +$30.8K | ﹤0.01% | 1565 |
|
|
2019
Q4 | $1.8M | Buy |
100,100
+2,400
| +2% | +$43.2K | ﹤0.01% | 1787 |
|
|
2019
Q3 | $1.98M | Buy |
97,700
+2,800
| +3% | +$56.7K | ﹤0.01% | 1660 |
|
|
2019
Q2 | $2.1M | Buy |
94,900
+14,300
| +18% | +$316K | ﹤0.01% | 1665 |
|
|
2019
Q1 | $1.1M | Buy |
80,600
+2,600
| +3% | +$35.5K | ﹤0.01% | 2009 |
|
|
2018
Q4 | $706K | Buy |
78,000
+3,900
| +5% | +$35.3K | ﹤0.01% | 2197 |
|
|
2018
Q3 | $1.22M | Buy |
74,100
+3,600
| +5% | +$59.4K | ﹤0.01% | 2028 |
|
|
2018
Q2 | $987K | Buy |
70,500
+5,000
| +8% | +$70K | ﹤0.01% | 2165 |
|
|
2018
Q1 | $724K | Buy |
65,500
+7,800
| +14% | +$86.2K | ﹤0.01% | 2263 |
|
|
2017
Q4 | $508K | Buy |
57,700
+5,500
| +11% | +$48.4K | ﹤0.01% | 2405 |
|
|
2017
Q3 | $697K | Hold |
52,200
| – | – | ﹤0.01% | 2256 |
|
|
2017
Q2 | $749K | Hold |
52,200
| – | – | ﹤0.01% | 2226 |
|
|
2017
Q1 | $1.1M | Buy |
52,200
+14,900
| +40% | +$315K | ﹤0.01% | 1959 |
|
|
2016
Q4 | $1.05M | Hold |
37,300
| – | – | ﹤0.01% | 2001 |
|
|
2016
Q3 | $999K | Hold |
37,300
| – | – | ﹤0.01% | 1971 |
|
|
2016
Q2 | $630K | Buy |
37,300
+8,500
| +30% | +$144K | ﹤0.01% | 2227 |
|
|
2016
Q1 | $591K | Buy |
28,800
+5,300
| +23% | +$109K | ﹤0.01% | 2212 |
|
|
2015
Q4 | $540K | Buy |
23,500
+5,600
| +31% | +$129K | ﹤0.01% | 2214 |
|
|
2015
Q3 | $359K | Buy |
17,900
+9,700
| +118% | +$195K | ﹤0.01% | 2332 |
|
|
2015
Q2 | $237K | Buy |
+8,200
| New | +$237K | ﹤0.01% | 2514 |
|